ALPINE IMMUNE SCIENCES, INC. Quarterly Operating Income (Loss) in USD from Q1 2014 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Alpine Immune Sciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2014 to Q1 2024.
  • Alpine Immune Sciences, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$22.7M, a 45.6% decline year-over-year.
  • Alpine Immune Sciences, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$51.4M, a 22.5% increase year-over-year.
  • Alpine Immune Sciences, Inc. annual Operating Income (Loss) for 2023 was -$44.3M, a 23.9% increase from 2022.
  • Alpine Immune Sciences, Inc. annual Operating Income (Loss) for 2022 was -$58.1M, a 16.6% decline from 2021.
  • Alpine Immune Sciences, Inc. annual Operating Income (Loss) for 2021 was -$49.9M, a 73.4% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$51.4M -$22.7M -$7.1M -45.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$44.3M $1.55M +$21.9M Oct 1, 2023 Dec 31, 2023 10-K 2024-03-20
Q3 2023 -$66.2M -$14.6M -$718K -5.19% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$65.4M -$15.7M +$834K +5.06% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$66.3M -$15.6M -$8.14M -109% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$58.1M -$20.4M -$4.99M -32.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-20
Q3 2022 -$53.2M -$13.8M -$569K -4.29% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$52.6M -$16.5M -$5.76M -53.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$46.8M -$7.46M +$3.03M +28.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$49.9M -$15.4M -$8.92M -138% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-20
Q3 2021 -$40.9M -$13.3M -$6.29M -90.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$34.7M -$10.7M -$979K -10% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$33.7M -$10.5M -$4.92M -88.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$28.7M -$6.46M +$556K +7.92% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-23
Q3 2020 -$29.3M -$6.97M +$4.74M +40.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$34M -$9.75M +$2.4M +19.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 -$36.4M -$5.57M +$7.13M +56.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$43.6M -$7.02M +$4.43M +38.7% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-17
Q3 2019 -$48M -$11.7M +$676K +5.46% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$48.7M -$12.2M -$3.74M -44.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 -$44.9M -$12.7M -$7.11M -127% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 -$37.8M -$11.4M -$6.66M -139% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-18
Q3 2018 -$31.2M -$12.4M -$7.83M -172% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$23.3M -$8.41M -$4.78M -131% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 -$18.6M -$5.59M -$3.59M -180% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$15M -$4.79M +$3.04M +38.8% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-30
Q3 2017 -$18M -$4.55M -$4.17M -1095% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$13.8M -$3.64M +$4.96M +57.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$18.8M -$1.99M +$5.94M +74.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 -$24.7M -$7.82M -$1.19M -18% Oct 1, 2016 Dec 31, 2016 10-K 2017-02-13
Q3 2016 -$23.5M -$381K +$5.72M +93.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$29.3M -$8.6M -$2.74M -46.9% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-21
Q1 2016 -$26.5M -$7.93M -$3.62M -83.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-02
Q4 2015 -$22.9M -$6.63M -$3.14M -90.2% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-13
Q3 2015 -$19.8M -$6.1M -$3.45M -130% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-13
Q2 2015 -$16.3M -$5.85M -$1.9M -47.9% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-13
Q1 2015 -$14.4M -$4.32M +$75K +1.71% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-13
Q4 2014 -$14.5M -$3.49M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-08
Q3 2014 -$2.65M Jul 1, 2014 Sep 30, 2014 10-K 2016-03-08
Q2 2014 -$3.96M Apr 1, 2014 Jun 30, 2014 10-K 2016-03-08
Q1 2014 -$4.39M Jan 1, 2014 Mar 31, 2014 10-K 2016-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.